Literature DB >> 29432862

Responsible Epidemiologic Research Practice: a guideline developed by a working group of the Netherlands Epidemiological Society.

Gerard M H Swaen1, Miranda Langendam2, Joost Weyler3, Huibert Burger4, Sabine Siesling5, Willem Jan Atsma6, Lex Bouter7.   

Abstract

OBJECTIVES: To develop a guideline on Responsible Epidemiologic Research Practice that will increase value and transparency, increase the accountability of the epidemiologists, and reduce research waste.
SETTING: A working group of the Netherland Epidemiological Society was given the task of developing a guideline that would meet these objectives. Several publications about the need to prevent Detrimental Research Practices triggered this work. Among these were a series in the Lancet on research waste and a subsequent series on transparency in the Journal of Clinical Epidemiology. The reputation and trust in epidemiologic research is still high, and the Netherlands Epidemiological Society wishes to keep it that way. The guideline deals with how epidemiologic research should be conducted, archived, and disclosed. It does not deal with the more technical aspects, such as required sample size, choice of study design, and so forth. The guideline describes each step in the process of conducting an epidemiologic study, from the first idea to the ultimate publication and beyond.
METHODS: The working group reviewed the literature on responsible research conduct, including the various existing codes of conduct. It applied the general principles from these codes to the elements of an epidemiologic study and formulated specific recommendations for each of these. Next step was to draft the guideline. Preceding the 2016 annual national epidemiology conference in Wageningen, a preconference was organized to discuss the draft guideline and to assess support. Support was clearly present, and the provided recommendations were incorporated into the draft guideline. In March 2017, a draft version of the guideline was sent to all 1,100 members of the society with the request to review and provide comments. All received responses were positive, and some minor additions were made. The Responsible Epidemiologic Research Practice guideline has now been approved by the board of the Netherlands Epidemiological Society.
CONCLUSION: With the Responsible Epidemiologic Research Practice guideline, we hope to contribute to better research practices in epidemiology but perhaps also in adjacent disciplines.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Keywords:  Accountability and transparency; Detrimental research practices; Outcome reporting bias; Questionable research practices; Research integrity; Research practice

Mesh:

Year:  2018        PMID: 29432862     DOI: 10.1016/j.jclinepi.2018.02.010

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  4 in total

1.  Guidelines and recommendations for ensuring Good Epidemiological Practice (GEP): a guideline developed by the German Society for Epidemiology.

Authors:  Wolfgang Hoffmann; Ute Latza; Sebastian E Baumeister; Martin Brünger; Nina Buttmann-Schweiger; Juliane Hardt; Verena Hoffmann; André Karch; Adrian Richter; Carsten Oliver Schmidt; Irene Schmidtmann; Enno Swart; Neeltje van den Berg
Journal:  Eur J Epidemiol       Date:  2019-03-04       Impact factor: 8.082

2.  The strong focus on positive results in abstracts may cause bias in systematic reviews: a case study on abstract reporting bias.

Authors:  Bram Duyx; Gerard M H Swaen; Miriam J E Urlings; Lex M Bouter; Maurice P Zeegers
Journal:  Syst Rev       Date:  2019-07-17

3.  Whatever can go wrong, need not go wrong: Open Quality approach for epidemiology.

Authors:  Sandra Alba; Masja Straetemans
Journal:  Emerg Themes Epidemiol       Date:  2021-07-17

4.  Bridging research integrity and global health epidemiology (BRIDGE) statement: guidelines for good epidemiological practice.

Authors:  Sandra Alba; Kristien Verdonck; Annick Lenglet; Susan F Rumisha; Martijn Wienia; Imre Teunissen; Masja Straetemans; Walter Mendoza; Daniel Jeannetot; Daniel Weibel; Harriet Mayanja-Kizza; Sanjay Juvekar
Journal:  BMJ Glob Health       Date:  2020-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.